Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Net Cash Flow (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 16 years of Net Cash Flow data on record, last reported at -$57.0 million in Q4 2025.

  • For Q4 2025, Net Cash Flow fell 4142.91% year-over-year to -$57.0 million; the TTM value through Dec 2025 reached $10.3 million, up 189.88%, while the annual FY2025 figure was $52.0 million, 526.13% up from the prior year.
  • Net Cash Flow reached -$57.0 million in Q4 2025 per PBH's latest filing, down from -$20.4 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $131.6 million in Q2 2021 and bottomed at -$119.9 million in Q3 2021.
  • Average Net Cash Flow over 5 years is $89700.0, with a median of $1.8 million recorded in 2023.
  • Peak YoY movement for Net Cash Flow: soared 439.6% in 2021, then tumbled 4142.91% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$21.6 million in 2021, then surged by 299.9% to $43.1 million in 2022, then crashed by 95.05% to $2.1 million in 2023, then tumbled by 33.9% to $1.4 million in 2024, then crashed by 4142.91% to -$57.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were -$57.0 million in Q4 2025, -$20.4 million in Q3 2025, and $40.8 million in Q2 2025.